Skip to search formSkip to main contentSkip to account menu

vedolizumab

Known as: Immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer's patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus kappa-chain, dimer 
A recombinant humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the human lymphocyte Peyer's patch adhesion molecule 1 (LPAM-1… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Highly Cited
2017
Highly Cited
2017
Vedolizumab is a gut‐selective immunoglobulin G1 monoclonal antibody to α4β7 integrin for the treatment of Crohn's disease (CD… 
Highly Cited
2017
Highly Cited
2017
Background: Vedolizumab is a gut-selective &agr;4&bgr;7 integrin antagonist for the treatment of moderately to severely active… 
Highly Cited
2001
Highly Cited
2001
We have previously observed that female MF1 mice appeared to reach a limit in their food intake and milk production during late… 
Highly Cited
2001
Highly Cited
2001
Laboratory mice (strain MF1) were used to determine whether sustainable rates of energy intake are limited during lactation. Mice… 
Highly Cited
1982
Highly Cited
1982
The endogenous ecotropic murine leukemia virus DNA content and integration sites were characterized for 54 inbred strains and… 
Highly Cited
1976
Highly Cited
1976
The development of hearing in the house mouse (Mus musculus) was behaviorally tested from the first postnatally measurable… 
Highly Cited
1974
Highly Cited
1974
The genetic control of the sterility of male hybrids between certain laboratory and wild mice (Mus musculus L.) is investigated…